Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine versus phenylephrine for cerebral bypass perfusion
NL-OMON23040Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dobutamine and phenylephrine in cerebral hypoperfusion (CCH) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Change in graft flow after cardiac output increase and Change in graft flow after blood pressure increase. Started Jul 2018; status: active, not recruiting.
02
Drugs
dobutaminephenylephrine
03
Conditions
cerebral hypoperfusion (CCH)
Beyond the preview
Go deeper on NL-OMON23040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23040.